Postdoctoral Scientist – Molecular Oncology Group

 

Salary in the range of £30,000 – £39,800 dependent upon qualifications and experience

Job Ref: MI/15/73-3

3 year fixed term position

 

A three-year postdoctoral position funded by the EU Horizon 2020 Programme is available in the laboratory of Prof. Richard Marais to identify and validate novel therapeutic approaches for the treatment of metastatic uveal melanoma (UM). The project aims to integrate knowledge gained from the study of in vitro and in vivo models of metastatic UM with patient derived genomic data and translate this to clinical benefit for UM patients.

 

The successful applicant should have a PhD in cell biology, biochemistry, or a relevant field. A background in melanoma, photobiology or use of in vivo cancer models is desirable but not required.

 

The Cancer Research UK Manchester Institute (www.cruk.manchester.ac.uk), an Institute of The University of Manchester (www.manchester.ac.uk), is a world-leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (www.cancerresearchuk.org), the largest independent cancer research organisation in the world. We are adjacent to The Christie NHS Foundation Trust (www.christie.nhs.uk), one of the largest cancer treatment centres in Europe. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

 

Our aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients. Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials.

 

The Institute has outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass-spectrometry.